647 filings
Page 16 of 33
8-K
for ow7zsxsvmw
7 Jan 13
AMAG Pharmaceuticals Provides Business Update
12:00am
8-K
lbw1rzvw42wrua9yi
21 Nov 12
Other Events
12:00am
CT ORDER
dkec89m924t
16 Nov 12
Confidential treatment order
12:00am
8-K
zyvzl40 nilne
1 Nov 12
Results of Operations and Financial Condition
12:00am
UPLOAD
dpn6z36
1 Oct 12
Letter from SEC
12:00am
CORRESP
a2s6drsy
14 Sep 12
Correspondence with SEC
12:00am
CT ORDER
is4lv71
4 Sep 12
Confidential treatment order
12:00am
8-K
wo75glegtha
31 Aug 12
Entry into a Material Definitive Agreement
12:00am
CORRESP
3u5fe6x
24 Aug 12
Correspondence with SEC
12:00am
UPLOAD
3gv4 ojo9dx
17 Aug 12
Letter from SEC
12:00am
8-K/A
4kosi go7
7 Aug 12
Cost Associated with Exit or Disposal Activities
12:00am
8-K
70fp66ux za7fc
26 Jul 12
Results of Operations and Financial Condition
12:00am
S-8
e2dv8txhhrb4
24 Jul 12
Registration of securities for employees
12:00am
8-K
cuo5r0t q54ya4
18 Jul 12
FerahemeĀ®Ā Achieves Superiority on all Primary Efficacy Endpoints
12:00am
8-K
nz33wk7pl
29 Jun 12
AMAG Pharmaceuticals Realigns Operating Cost Structure to Focus on Continued Feraheme Growth and Business Development Activities
12:00am
8-K
hk1wpn h6hb9gn179
25 May 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
0lpvcn
10 May 12
AMAG Pharmaceuticals Appoints William Heiden as President and Chief Executive Officer
12:00am
DEFA14A
yevst1fn
10 May 12
Additional proxy soliciting materials
12:00am